Jul 2, 2026 08:30AM
Jun 16, 2026 08:02AM
Jun 4, 2026 04:48PM
Jun 2, 2026 08:01AM
Jun 2, 2026 07:59AM
May 26, 2026 06:59AM
May 19, 2026 04:53PM Cingulate board to shrink to five directors after 2026 meeting
May 14, 2026 08:03AM
Apr 6, 2026 04:34PM
Mar 23, 2026 09:11AM
Jan 15, 2026 04:08PM
Jan 12, 2026 05:11PM
Nov 18, 2025 04:27PM
Oct 14, 2025 08:04AM FDA accepts Cingulate's drug application for ADHD treatment CTx-1301
Sep 17, 2025 08:45AM
Aug 22, 2025 06:21AM
Aug 21, 2025 04:35PM
Aug 15, 2025 09:02AM
Aug 6, 2025 08:45AM
Jul 29, 2025 08:01AM
Jul 25, 2025 04:30PM Cingulate Inc (CING) Files for 2.5M Share Offering by Selling Stockholders
Jul 9, 2025 08:03AM
Jun 18, 2025 08:00AM
May 20, 2025 08:03AM
May 14, 2025 08:04AM
Apr 9, 2025 08:00AM
Apr 3, 2025 08:06AM
Mar 4, 2025 09:02AM Cingulate Inc (CING) Reports Safety Results from Final Phase 3 Trials for CTx-1301
Jan 30, 2025 06:40AM
Jan 10, 2025 08:59AM
Oct 7, 2024 09:06AM
Sep 27, 2024 06:30AM
Aug 19, 2024 06:54AM
Aug 16, 2024 11:33AM
Aug 15, 2024 07:45AM Cingulate Inc (CING) Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHD
Aug 13, 2024 10:23AM
Jun 28, 2024 09:16AM
Jun 25, 2024 09:20AM

415,733 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All